Xspray-logo-white
  • Home
  • About us
    • Business model
    • Our history – a timeline
    • Board of Directors & Board committees
    • Management
  • Technology
  • Pipeline
  • Media
  • Contact
  • Investors
  • en en
    • sv sv
  • Investors
    • Share information
      • Analysts
      • Trading information
      • Ownership structure
    • Financial calendar & Events
    • Financial reports
      • ESEF report
    • Prospectus
    • Press releases
    • Corporate governance
      • Corporate Structure
      • General meetings
      • Corporate Governance Reports
      • Nomination committee
      • Board of Directors & Board committees
      • Management
      • Accounting principles
      • Internal control & Risk management
      • Auditor
      • Articles of association
      • Renumeration

Financial reports

2022

Interim Report Q1 2022
Interim Report Q2 2022
Interim Report Q3 2022

2021

Interim Report Q1 2021
Interim Report Q2 2021
Interim Report Q3 2021
Year End Report 2021
Annual Report 2021

2020

Interim Report Q1 2020
Interim Report Q2 2020
Interim Report Q3 2020
Year End Report 2020
Annual Report 2020

2019

Interim Report Q1 2019
Interim Report Q2 2019
Interim Report Q3 2019
Year End Report 2019
Annual Report 2019

2018

Year End Report 2018
Annual Report 2018

2017

Xspray-logo-white

Xspray Pharma AB Råsundavägen 12 169 67 Solna

+46 (0)8 730 37 00 info@xspraypharma.com